Cairo – Mubasher: Ibnsina Pharma plans to inject about EGP 141 million in investments as part of its expansion plan in 2021.
These investments include EGP 59 million for new branches and the administrative headquarters as well as EGP 36 million for developing existing branches, the pharmaceutical company said in a bourse disclosure on Thursday.
The company also plans to invest EGP 34 million in technology and digital transformation projects and EGP 12 million in adding and renewing distribution vehicles.
In 2020, Ibnsina Pharma recorded net profits of EGP 224.66 million, down from EGP 328.77 million a year earlier, including minority shareholders’ rights.
